FSTL1 and hepatocellular carcinoma: found that follistatin-like 1 (FSTL1) secreted by activated fibroblasts drives stem cell characteristics, metastasis, and sorafenib resistance in HCC through the TLR4/AKT/mTOR/4EBP1 signaling axis.